Orzechowski Frank 4
4 · SIGMA LABS, INC. · Filed Jul 22, 2019
Insider Transaction Report
Form 4
SIGMA LABS, INC.SGLB
Orzechowski Frank
CFO, PFO and PAO
Transactions
- Award
Stock Option (right to buy)
2019-07-18+60,000→ 60,000 totalExercise: $1.40Exp: 2024-06-30→ Common Stock (60,000 underlying) - Award
Stock Option (right to buy)
2019-07-18+2,500→ 2,500 totalExercise: $1.40From: 2019-07-18Exp: 2024-06-30→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019.
- [F2]The stock option vests as follows: 3,872 shares will vest and become exercisable on July 1, 2020; 9,000 shares will vest and become exercisable on July 1, 2021; 14,128 shares will vest and become exercisable on July 1, 2022, and 33,000 shares will vest and become exercisable on July 1, 2023, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.